Cbd Life Sciences Stock Fundamentals
| CBDL Stock | USD 0.0005 0.0001 25.00% |
Cbd Life Sciences fundamentals help investors to digest information that contributes to Cbd Life's financial success or failures. It also enables traders to predict the movement of Cbd Pink Sheet. The fundamental analysis module provides a way to measure Cbd Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cbd Life pink sheet.
Cbd |
Cbd Life Sciences Company Current Valuation Analysis
Cbd Life's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Cbd Life Current Valuation | 51.93 K |
Most of Cbd Life's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cbd Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Cbd Life Sciences has a Current Valuation of 51.93 K. This is 100.0% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Cbd Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cbd Life's current stock value. Our valuation model uses many indicators to compare Cbd Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cbd Life competition to find correlations between indicators driving Cbd Life's intrinsic value. More Info.Cbd Life Sciences is rated fourth in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cbd Life's earnings, one of the primary drivers of an investment's value.Cbd Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cbd Life's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Cbd Life could also be used in its relative valuation, which is a method of valuing Cbd Life by comparing valuation metrics of similar companies.Cbd Life is currently under evaluation in current valuation category among its peers.
Cbd Fundamentals
| Return On Equity | -3.89 | |||
| Return On Asset | 0.0025 | |||
| Operating Margin | (23.29) % | |||
| Current Valuation | 51.93 K | |||
| Shares Outstanding | 3.58 K | |||
| Price To Sales | 0.26 X | |||
| Revenue | 138.19 K | |||
| Gross Profit | 27.43 K | |||
| EBITDA | (608.24 K) | |||
| Net Income | (6.14 M) | |||
| Cash And Equivalents | 303.09 K | |||
| Debt To Equity | 0.20 % | |||
| Current Ratio | 1.43 X | |||
| Cash Flow From Operations | (6.29 M) | |||
| Beta | 48.75 | |||
| Market Capitalization | 35.85 K |
About Cbd Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cbd Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cbd Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cbd Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. Cbd Life operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Cbd Pink Sheet
Cbd Life financial ratios help investors to determine whether Cbd Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cbd with respect to the benefits of owning Cbd Life security.